References
- Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human syndemic.
Clinical microbiology reviews. 2011;24(2):351-76.
- Meda ZC, Sombie I, Sanon OW, Mare D, Morisky DE, Chen YM. Risk factors
of tuberculosis infection among HIV/AIDS patients in Burkina Faso.
AIDS research and human retroviruses. 2013;29(7):1045-55.
- WHO: WHO policy on collaborative TB/HIV activities, Guidelines for
national programs, and other stakeholders. Geneva, Switzerland: World
Health Organization; 2012
- WHO: TB/HIV, HIV-Associated Tuberculosis Fact Sheet. Geneva,
Switzerland: World Health Organization; 2018.
- WHO: Global Tuberculosis Report. Geneva, Switzerland: World Health
Organization; 2019.
- WHO: Global Tuberculosis Report. Geneva, Switzerland: World Health
Organization; 2018.
- Alene KA, Viney K, Moore HC, Wagaw M, Clements ACA. Spatial patterns
of tuberculosis and HIV co-infection in Ethiopia. PLoS One.
2019;14(12):e0226127.
- Alemu YM, Awoke W, Wilder-Smith A. Determinants for tuberculosis in
HIV-infected adults in Northwest Ethiopia: a multicentre case-control
study. BMJ Open. 2016;6(4):e009058.
- Badri M, Wilson D, Wood R. Effect of highly active antiretroviral
therapy on incidence of tuberculosis in South Africa: a cohort study.
The Lancet. 2002;359(9323):2059-64.
- Cui Z, Lin M, Nie S, Lan R. Risk factors associated with Tuberculosis
(TB) among people living with HIV/AIDS: A pair-matched case-control
study in Guangxi, China. PLoS One. 2017;12(3):e0173976.
- Miranda A, Morgan M, Jamal L, Laserson K, Barreira D, et al (2007)
Impact of Antiretroviral Therapy on the Incidence of Tuberculosis: The
Brazilian Experience, 1995–2001. PLoS ONE.2007; 2(9): e826.
DOI:10.1371/journal.pone.0000826
- del Amo J, Moreno S, Bucher HC, Furrer H, Logan R, Sterne J, et al.
Impact of antiretroviral therapy on tuberculosis incidence among
HIV-positive patients in high-income countries. Clinical infectious
diseases: an official publication of the Infectious Diseases Society
of America. 2012;54(9):1364-72.
- Alemu A, Yesuf A, Zerihun B, Getu M, Worku T, Bitew ZW. Incidence and
determinants of tuberculosis among HIV-positive individuals in Addis
Ababa, Ethiopia: A retrospective cohort study. International Journal
of Infectious Diseases. 2020;95:59-66.
- Taha M, Deribew A, Tessema F, Assegid S, Duchateau L, Colebunders R.
Risk factors of active tuberculosis in people living with HIV/AIDS in
southwest Ethiopia: a case-control study. Ethiop J Health Science
2011; 21(2).
- Yirdaw KD, Teklu AM, Mamuye AT, Zewdu S. Breakthrough tuberculosis
disease among people with HIV - Should we be worried? A retrospective
longitudinal study. PLoS One. 2019;14(2):e0211688.
- Kibret KT, Yalew AW, Belaineh BG, Asres MM. Determinant factors
associated with occurrence of tuberculosis among adult people living
with HIV after antiretroviral treatment initiation in Addis Ababa,
Ethiopia: a case-control study. PLoS One. 2013;8(5):e64488.
- Azanaw MM, Derseh NM, Yetemegn GS, Angaw DA. Incidence and Predictors
of tuberculosis among HIV patients after initiation of ART treatment
in Ethiopia: A systematic review and Meta-analysis. Research square, a
preprint 2020; DOI: 10.21203/rs.2.19054/v1
- Mitku AA, Dessie ZG, Muluneh EK, Workie DL. Prevalence and associated
factors of TB/HIV co-infection among HIV Infected patients in Amhara
region, Ethiopia. African health sciences. 2016;16(2):588-95.
- Aemro A, Jember A, Anlay DZ. Incidence and predictors of tuberculosis
occurrence among adults on antiretroviral therapy at Debre Markos
referral hospital, Northwest Ethiopia: a retrospective follow-up
study. BMC Infect Dis. 2020;20(1):245.
- Girardi
E,
Sabin
CA,
Monforte
AA,
Hogg
B,
Phillips
AN, et al. Incidence of Tuberculosis among HIV-Infected Patients
Receiving Highly Active Antiretroviral Therapy in Europe and North
America. Clinical Infectious Diseases 2005;41:1772–82.
- Alene KA, Nega A, Taye BW. Incidence and predictors of tuberculosis
among adult people living with human immunodeficiency virus at the
University of Gondar Referral Hospital, Northwest Ethiopia. BMC
Infect Dis . 2013;13:292.
- Kassa A, Teka A, Shewaamare A, Jerene D. Incidence of tuberculosis and
early mortality in a large cohort of HIV infected patients receiving
antiretroviral therapy in a tertiary hospital in Addis Ababa,
Ethiopia. Trans R Soc Trop Med Hyg. 2012;106(6):363-70.
- Ahmed A, Mekonnen D, Shiferaw AM, Belayneh F, Yenit MK. Incidence and
determinants of tuberculosis infection among adult patients with HIV
attending HIV care in north-east Ethiopia: a retrospective cohort
study. BMJ Open. 2018;8(2):e016961.
- Alene KA, Nega A, Taye BW. Incidence and predictors of tuberculosis
among adult people living with human immunodeficiency virus at the
University of Gondar Referral Hospital, Northwest Ethiopia. BMC Infect
Dis 2013;13:292.
- Federal Democratic Republic of Ethiopia Ministry of Health; National
Comprehensive Tuberculosis, Leprosy and TB/HIV Training Manual for
Health Care Workers. 201626.
- Seyler C, Toure S, Messou E, Bonard D, Gabillard D, Anglaret X. Risk
factors for active tuberculosis after antiretroviral treatment
initiation in Abidjan. Am J Respir Crit Care Med. 2005;172(1):123-7.
- Nugus GG, Irena ME. Determinants of Active Tuberculosis Occurrences
after ART Initiation among Adult HIV-Positive Clients in West Showa
Zone Public Hospitals, Ethiopia: A Case-Control Study. Advances in
Public Health. 2020;2020:1-8.
- Unis G, Ribeiro AW, Esteves LS, et al. Tuberculosis recurrence in a
high incidence setting for HIV and tuberculosis in Brazil. BMC
Infectious Diseases . 2014, 14:548.
- Brinkhof
MWG,
Egger
E,
Boulle
A, May
M, Hosseinipour
M, et al.Tuberculosis after Initiation of Antiretroviral Therapy in
Low-Income and High-Income Countries. Clinical Infectious Diseases.
2007;45(11):1518-21.
- Tiruneh G, Getahun A, Adeba E. Assessing the Impact of Isoniazid
Preventive Therapy (IPT) on Tuberculosis Incidence and Predictors of
Tuberculosis among Adult Patients Enrolled on ART in Nekemte Town,
Western Ethiopia: A Retrospective Cohort Study. Interdisciplinary
perspectives on infectious diseases. 2019;2019:1413427.
- Gunda DW, Maganga SC, Nkandala I, Kilonzo SB, Mpondo BC, Shao ER, et
al. Prevalence and Risk Factors of Active TB among Adult HIV Patients
Receiving ART in Northwestern Tanzania: A Retrospective Cohort Study.
The Canadian journal of infectious diseases & medical microbiology.
2018;2018:1346104.
- Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, et
al. Late-disease stage at presentation to an HIV clinic in the era of
free antiretroviral therapy in Sub-Saharan Africa. Journal of acquired
immune deficiency syndromes (1999). 2009;52(2):280-9.
- Hu X, Liang B, Zhou C, Jiang J, Huang J, Ning C, et al. HIV late
presentation and advanced HIV disease among patients with newly
diagnosed HIV/AIDS in Southwestern China: a large-scale
cross-sectional study. AIDS research and therapy. 2019;16(1):6.
- Dravid A, Natarajan K, Medisetty M, Gawali R, Mahajan U, Kulkarni M,
et al. Incidence of tuberculosis among HIV infected individuals on
long term antiretroviral therapy in private healthcare sector in Pune,
Western India. BMC Infect Dis. 2019;19(1):714.
- WHO: Implementing the WHO Stop TB Strategy. Geneva, Switzerland: World
Health Organization; 2008.
- Pettit AC, Jenkins CA, Stinnette SE, Rebeiro PF, Blackwell RB,
Raffanti SP, et al. Tuberculosis risk before and after highly active
antiretroviral therapy initiation: does HAART increase the short-term
TB risk in a low incidence TB setting? Journal of acquired immune
deficiency syndromes. 2011;57(4):305-10.
- Van Rie A, Westreich D, Sanne I. Tuberculosis in patients receiving
antiretroviral treatment: incidence, risk factors, and prevention
strategies. Journal of acquired immune deficiency syndromes.
2011;56(4):349-55.
- Ali K, Klotz SA. The immune reconstitution inflammatory syndrome with
tuberculosis: a common problem in Ethiopian HIV-infected patients
beginning antiretroviral therapy. J Int Assoc Physicians AIDS Care
(Chic). 2012;11(3):198-202.